Severe pediatric neurological manifestations with SARS-CoV-2 or MIS-C hospitalization and new morbidity

JAMA Network Open

2024-06-10

(Press-News.org) About The Study: The results of this study suggest that children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome in children (MIS-C) and severe neurological manifestations may be at high risk for long-term impairment and may benefit from screening and early intervention to assist recovery.

Corresponding Author: To contact the corresponding author, Ericka L. Fink, M.D., M.S., email finkel@ccm.upmc.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2024.14122)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.14122?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=061024

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Elephants have names for each other like people do, new study shows

2024-06-10

Colorado State University scientists have called elephants by their names, and the elephants called back. Wild African elephants address each other with name-like calls, a rare ability among nonhuman animals, according to a new study published in Nature Ecology and Evolution. Researchers from CSU, Save the Elephants and ElephantVoices used machine learning to confirm that elephant calls contained a name-like component identifying the intended recipient, a behavior they suspected based on observation. When the researchers played back recorded calls, elephants responded affirmatively ...

In a significant first, researchers detect water frost on solar system’s tallest volcanoes

2024-06-10

PROVIDENCE, R.I. [Brown University] — An international team of planetary scientists has detected patches of water frost sitting atop the Tharsis volcanoes on Mars, which are not only the tallest volcanic mountains on the Red Planet but in the entire solar system. The discovery marks the first time frost has been spotted near the planet’s equator, challenging existing perceptions of the planet’s climate dynamics, according to the team’s new study in Nature Geoscience. “We thought it was improbable for frost to form around Mars’ equator, as the mix ...

Super-chilled brain cell molecules reveal how epilepsy drug works

2024-06-10

FOR IMMEDIATE RELEASE By super cooling a molecule on the surface of brain cells down to about minus 180 degrees Celsius — nearly twice as cold as the coldest places in Antarctica — scientists at Johns Hopkins Medicine say they have determined how a widely-used epilepsy drug works to dampen the excitability of brain cells and help to control, although not cure, seizures. The research, published June 4 in Nature Structural & Molecular Biology, identifies critical connections between activity of the epilepsy drug ...

Benefits of failure are overrated

2024-06-10

The platitude that failure leads to success may be both inaccurate and damaging to society, according to research published by the American Psychological Association. Researchers conducted 11 experiments with more than 1,800 participants across many domains and compared national statistics to the participants’ responses. In one experiment, participants vastly overestimated the percentage of prospective nurses, lawyers and teachers who pass licensing exams after previously failing them. “People expect success to follow failure much more often than it actually does,” said lead researcher Lauren Eskreis-Winkler, PhD, an assistant ...

NUTRITION 2024 showcases groundbreaking research on what we eat and why it matters

2024-06-10

Don’t miss your chance to be among the first to hear breaking news in food and nutrition science at NUTRITION 2024. The annual flagship meeting of the American Society for Nutrition will be held June 29–July 2 at McCormick Place in Chicago. Reporters and bloggers are invited to explore the meeting schedule and register for a complimentary press pass to attend. The meeting will feature stimulating discussions, exciting research announcements and updates from groups shaping the nutrition and health policies that affect us all. Highlights include: Diet and exercise performance – As the ...

Icahn School of Medicine at Mount Sinai awarded $21 million NIH grant to advance understanding of aging-related hormone

2024-06-10

New York, NY [June 10, 2024]—Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $21 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH), to further advance understanding of an aging-related hormone known as follicle-stimulating hormone (FSH), including its potential role in obesity, osteoporosis, and Alzheimer’s disease. The work could lead to the development of new treatments for these and other conditions involving aging. This is a collaborative ...

RNA splicing’s spotters

2024-06-10

Bodybuilders and cellular mechanisms agree generating protein is a heavy lift. To complete the task, cells rely on complexes called spliceosomes. These molecular machines snip extra bits out of our genes’ RNA copies and piece together precise instructions for protein-building. When the splicing process goes awry, it can result in diseases like cancer or spinal muscular atrophy. Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer helped develop the first FDA-approved treatment for this devastating genetic disorder. Now, his team has discovered that two important regulator proteins work together ...

Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use

2024-06-10

A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment, UCLA-led research suggests. Participants in the ADAPT-2 clinical trial who received a combination of injectable naltrexone plus extended-release oral bupropion (NTX+BUPN) had a 27% increase in methamphetamine-negative urine tests, indicating reduced usage. By contrast, the placebo group had an 11% increase in negative tests. The study will be published in the peer-reviewed journal Addiction. “These ...

Gut microbes from aged mice induce inflammation in young mice, study finds

2024-06-10

CHAMPAIGN, Ill. — When scientists transplanted the gut microbes of aged mice into young “germ-free” mice — raised to have no gut microbes of their own — the recipient mice experienced an increase in inflammation that parallels inflammatory processes associated with aging in humans. Young germ-free mice transplanted with microbes from other young mice had no such increase. The findings suggest that changes to the gut microbiome play a role in the systemwide inflammation that often occurs ...

Valentin Fuster, MD, Ph.D., received 2024 Distinguished Award from European Society for Clinical Investigation (ESCI)

2024-06-10

The European Society for Clinical Investigation (ESCI) is awarding Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, its ESCI Distinguished Medal for 2024. He received this honor during the ESCI Annual Scientific Meeting in Barcelona, Spain, during a special ceremony on Friday, June 7. The ESCI Medal is awarded yearly for outstanding achievements in clinical investigation and for the teaching of young scientists and medical specialists. This prestigious recognition highlights Dr. Fuster’s significant contributions to the worldwide field of cardiology. Dr. Fuster’s work has been ...

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

Severe pediatric neurological manifestations with SARS-CoV-2 or MIS-C hospitalization and new morbidity

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: